Vanguard Capital Management’s Avanos Medical AVNS Stock Holding History

Vanguard Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.6M	Buy	+1,971,965	New	+$26.6M	﹤0.01%	2171

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Vanguard Capital Management's AVNS Position: Q1 2026 in Review

Vanguard Capital Management opened a new position in Avanos Medical (AVNS) in Q1 2026: 1,971,965 shares worth $27.6M. The stake represents ﹤0.01% of the portfolio and ranks #2171 among its holdings.

257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

Vanguard Capital Management held 1,971,965 shares of Avanos Medical worth $27.6M as of Q1 2026.
Avanos Medical was a new Vanguard Capital Management position in Q1 2026.
Avanos Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q1 2026, its #2171 holding.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.